HES1 and lip and oral cavity carcinoma: We report the molecular docking analysis data for oral cancer drug, cetuximab with NOTCH signaling pathway targets such as NOTCH1, NICD and HES1 which regulates Epithelial Mesenchymal Transition (EMT).